Effects of germanium organic compound and α-lipoic acid on STZ-induced diabetes manifestations in rats DOI Creative Commons

Ya. V. Rozhkovskyi

Regulatory Mechanisms in Biosystems, Год журнала: 2024, Номер 15(4), С. 962 - 969

Опубликована: Ноя. 18, 2024

Deep deteriorations accompany diabetes in all types of metabolism with an impact on functional activity and complications that are vital significance. Damage to the liver contributes worsening patient's state. Oxidative stress makes a pivotal contribution diabetes-induced disorders. The investigation niacin-oxyethylidene-diphosphonate germanate (MIGU-4) α-lipoic acid treatment, which both possessed antioxidative properties upon state rats streptozotocin induced diabetes, was aim investigation. Treatment MIGU-4 (25.0 mg/kg, i.p.) (50.0 started six weeks after induction by (65.0 administration.and performed daily for further weeks. results obtained revealed combined administration mg/kg) caused increase albumin decrease bilirubin when compared streptozotocin-treated rats. Administration reduction cholesterol triglycerides, low-density lipoproteins, while high-density lipoproteins increased. Besides, treatment reduced malone dialdehyde, increased glutathione content, superoxide dismutase catalase streptozotocin-diabetes. protective effect is more pronounced than alone. There ample scope investigations treating damage complex metabolic

Язык: Английский

The role and mechanism of m6A methylation in diabetic nephropathy DOI
Lin-Jing Yan, Liang Guo

Life Sciences, Год журнала: 2025, Номер 363, С. 123355 - 123355

Опубликована: Янв. 6, 2025

Язык: Английский

Процитировано

1

Global and national public awareness and interest in glomerular diseases from 2004 to 2024 DOI Creative Commons

Suryanarayanan Balakrishnan,

Charat Thongprayoon,

Iasmina Craici

и другие.

Frontiers in Nephrology, Год журнала: 2025, Номер 5

Опубликована: Янв. 23, 2025

Background Glomerular diseases significantly impact global health. This study investigated public interest in five common glomerular diseases. Methods Google Trends™ were used to analyze search activity from January 2004 December 2024 for IgA nephropathy (IgAN), membranous glomerulonephritis (MN), focal segmental glomerulosclerosis (FSGS), lupus nephritis (LN), and diabetic (DN). Data retrieved both globally English-speaking countries, including the United States. Monthly yearly relative assessed compared. Results Globally, IgAN had highest average activity, followed by DN, FSGS, LN, MN. Both FSGS exhibited declining trends, while LN showed an upward pattern. MN DN experienced a modest decline before 2016, preceded slight increase. Among was predominantly concentrated primarily States, Kingdom, Canada, Australia, with States consistently ranking as leading country. For IgAN, MN, trends observed appeared align data. In contrast, exceeded levels, slightly lower than activity. most prominent North Dakota, Massachusetts, Delaware, respectively, saw peak West Virginia. Conclusion Public engagement has not uniformly grown, at least emphasizing need enhanced awareness efforts. Future analysis should prioritize terms predominant language of each

Язык: Английский

Процитировано

0

Fructus arctii mitigates diabetic nephropathy via the Apoh/PPAR-γ pathway DOI
Na Zhang,

Anhui Chen,

Yuwei Dong

и другие.

Molecular Immunology, Год журнала: 2025, Номер 181, С. 18 - 28

Опубликована: Март 7, 2025

Язык: Английский

Процитировано

0

Integrative analysis of mitochondrial and immune pathways in diabetic kidney disease: identification of AASS and CASP3 as key predictors and therapeutic targets DOI Creative Commons
Xin‐Xin Yu,

Yongzheng Hu,

Wei Jiang

и другие.

Renal Failure, Год журнала: 2025, Номер 47(1)

Опубликована: Фев. 23, 2025

Objectives Diabetic kidney disease (DKD) is driven by mitochondrial dysfunction and immune dysregulation, yet the mechanistic interplay remains poorly defined. This study aimed to identify key molecular networks linking pathways DKD progression, with a focus on uncovering biomarkers therapeutic targets.

Язык: Английский

Процитировано

0

Combining mitochondrial proteomes and Mendelian randomization to identify novel therapeutic targets for diabetic nephropathy DOI Creative Commons
Yang Liu, Rong Wu, Zhenlei Zhou

и другие.

Renal Failure, Год журнала: 2025, Номер 47(1)

Опубликована: Март 24, 2025

Diabetic nephropathy (DN) is a common microvascular complication of diabetes. Mitochondrial dysfunction in the kidney caused by diabetes has previously been linked to pathogenesis DN. By mass spectrometry, we identified characteristic proteins DN from renal mitochondria mouse model. To identify core among them, Mendelian randomization (MR) analysis, microarray data validation, and drug-target interaction analysis were employed. MR found that 189 candidate targets had causal link with risk factors (estimated glomerular filtration rate (eGFR), urinary albumin excretion, serum creatinine). After systematic validated SLC25A16, CTNND1, C2CD2L, ALDH3A2, NEU1, APEH, CORO1A, NUDT19, NDUFA4L2 are promising druggability This study suggests feasibility using for drug target screening, provides potential insights into mitochondrial research, which may contribute further exploration.

Язык: Английский

Процитировано

0

Mapping the future: bibliometric insights into ferroptosis and diabetic nephropathy DOI Creative Commons
Tao Wei, Yang Qin,

Xiaohui Lin

и другие.

Frontiers in Physiology, Год журнала: 2025, Номер 16

Опубликована: Апрель 10, 2025

Background Diabetic nephropathy (DN), a leading cause of end-stage renal disease, exerts substantial burden on healthcare systems globally. Emerging evidence highlights ferroptosis - an iron-dependent form cell death driven by lipid peroxidation and glutathione depletion as critical contributor to DN progression via oxidative stress, tubular injury, glomerular dysfunction. Despite increasing research interest, comprehensive synthesis trends mechanistic insights is lacking. Objective This study integrated bibliometric analysis with review map the evolving landscape in DN, identify hotspots, propose future directions for therapeutic development. Methods In total, 86 publications (2018–2023) were retrieved from Web Science Core Collection analyzed using CiteSpace VOSviewer. Co-occurrence networks, citation trends, keyword bursts examined delineate global contributions, collaborative emerging themes. Results Annual publication numbers surged 12-fold after 2020, China contributing highest proportion (60.4%), led institutions such Zhengzhou University. The United States America Germany showed high centrality networks. Key themes included peroxidase 4 (GPX4)-mediated antioxidant defenses, acyl-CoA synthetase long-chain family member (ACSL4)-mediated remodeling, iron dysregulation. Frontiers Endocrinology (nine articles) Free Radical Biology Medicine (highest count: 171) emerged pivotal platforms. Mechanistic analyses identified three defense axes (GPX4, FSP1/CoQ10, GCH1/BH4) type-specific vulnerabilities tubular, podocyte, endothelial cells. Preclinical agents, including ginkgolide B (GB) dapagliflozin, effectively restored homeostasis attenuated damage. Conclusion Ferroptosis promising target yet its clinical translation remains infancy. Future efforts should prioritize large-scale trials, single-cell profiling, interdisciplinary integration bridge molecular precision therapies. provides roadmap advancing ferroptosis-targeted interventions emphasizing collaborations biomarker-driven strategies.

Язык: Английский

Процитировано

0

Diabetic Nephropathy: Pathogenesis, Mechanisms, and Therapeutic Strategies DOI

Shivangi Dwivedi,

Mukesh Singh Sikarwar

Hormone and Metabolic Research, Год журнала: 2024, Номер unknown

Опубликована: Ноя. 21, 2024

Abstract Diabetic nephropathy represents a predominant etiology of end-stage renal disease (ESRD) on global scale, significantly impacting the morbidity and mortality rates individuals with diabetes. The primary objective this analysis is to furnish comprehensive examination etiology, fundamental mechanisms, treatment modalities for DN. development DN stems from multitude factors, encompassing intricate interplay involving metabolic irregularities induced by hyperglycemia, alterations in hemodynamics, inflammatory responses, oxidative stress, genetic susceptibility. Principal mechanisms encompass generation advanced glycation end products (AGEs), activation protein kinase C (PKC), overexpression renin-angiotensin-aldosterone system (RAAS). These processes precipitate glomerular hyperfiltration, hypertrophy, eventually, fibrosis scarring parenchyma. Initially, hyperglycemia triggers mesangial proliferation thickening basement membrane incipient stages DN, subsequently leading progressive sclerosis tubulointerstitial fibrosis. Inflammatory cascades, notably cytokines like TGF-β NF-κB, play pivotal roles advancement fostering accumulation extracellular matrix Inflammation pathways, particularly those essential diabetic progression stimulating presence worsened dysfunctional mitochondria, contributes further injury via lipid peroxidation DNA damage. Current therapeutic approaches concentrate optimizing glycemic control, controlling hypertension, suppressing system. Among antihypertensive medications, ACE inhibitors angiotensin II receptor blockers are crucial decelerating advancement.

Язык: Английский

Процитировано

3

Molecular mechanisms of diabetic nephropathy: A narrative review DOI
Tian Sun,

Yina Guo,

Yanting Su

и другие.

Cell Biology International, Год журнала: 2024, Номер 48(9), С. 1240 - 1253

Опубликована: Июнь 30, 2024

Abstract Diabetic nephropathy (DN) is the predominant secondary resulting in global end‐stage renal disease. It attracting significant attention both domestic and international research due to its widespread occurrence, fast advancement, limited choices for prevention treatment. The pathophysiology of this condition intricate involves multiple molecular cellular pathways at various levels. This article provides a concise overview processes involved development DN. discusses factors, such as signaling pathways, cytokines, inflammatory responses, oxidative stress, damage, autophagy, epigenetics. aim offer clinicians valuable reference DN's diagnosis, treatment, intervention.

Язык: Английский

Процитировано

2

Chinese herbal medicine for the treatment of diabetic nephropathy: From clinical evidence to potential mechanisms DOI
Xiaoxiao Gong, Linhai Cao, Hongxia Ni

и другие.

Journal of Ethnopharmacology, Год журнала: 2024, Номер 330, С. 118179 - 118179

Опубликована: Апрель 16, 2024

Язык: Английский

Процитировано

1

Serpin Family B Member 2 Polymorphisms in Patients with Diabetic Kidney Disease: An Association Study DOI Open Access
Maria Tziastoudi, Georgios Pissas,

Spyridon Golfinopoulos

и другие.

International Journal of Molecular Sciences, Год журнала: 2024, Номер 25(20), С. 10906 - 10906

Опубликована: Окт. 10, 2024

Diabetic kidney disease (DKD) is a serious microvascular complication of type 2 diabetes mellitus (T2DM). Despite the numerous genetic loci that have been associated with in T2DM, architecture DKD remains unclear until today. In contrast to SERPINE1, contribution SERPINB2 has not examined DKD. Therefore, we conducted first association study elucidate its role total, involved 197 patients DKD, 155 T2DM without complications (diabetic disease, diabetic retinopathy, and neuropathy), 246 healthy controls. The generalized odds ratio (ORG) was calculated estimate risk on development. present regarding SNPs (rs4941230, rs3819335, rs13381217, rs6140) did reveal any significant between variants Additional studies other populations are necessary further investigate this gene progression development

Язык: Английский

Процитировано

1